Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Doug Joshua"'
Autor:
Bradley Augustson, Simon J. Harrison, Andrew W. Roberts, Andrew C.W. Zannettino, Anna Kalff, Hang Quach, Jeff Szer, Noemi Horvath, Dipti Talaulikar, Akash Kalro, Andrew Spencer, Anna Johnston, Wilfrid J Jaksic, Doug Joshua, H. Miles Prince, Joy Ho, Oi Lin Lee, Cindy Lee, Silvia Ling, Chris Ward, John Gibson, Ross D. Brown, Peter Mollee
Publikováno v:
Internal Medicine Journal. 47:938-951
Multiple myeloma (MM) is a haematological malignancy characterised by the clonal proliferation of plasma cells in the bone marrow. More than 80% of patients with MM display evidence of myeloma bone disease (MBD), characterised by the formation of ost
Autor:
Doug Joshua, Andrew Spencer, Wilfrid J Jaksic, Hang Quach, Peter Mollee, Simon J. Harrison, Jeff Szer, Andrew W. Roberts, Joy Ho, Ross Brown, Noemi Horvath, D. Talulikar, L. Catley, Andrew C.W. Zannettino, Bik To, Henry Miles Prince, John Gibson, Bradley Augustson
Publikováno v:
Internal Medicine Journal. 45:94-105
Autor:
Oi Lin, Lee, Noemi, Horvath, Cindy, Lee, Doug, Joshua, Joy, Ho, Jeff, Szer, Hang, Quach, Andrew, Spencer, Simon, Harrison, Peter, Mollee, Andrew W, Roberts, Dipti, Talaulikar, Ross, Brown, Bradley, Augustson, Silvia, Ling, Wilfrid, Jaksic, John, Gibson, Anna, Kalff, Anna, Johnston, Akash, Kalro, Chris, Ward, H Miles, Prince, Andrew, Zannettino
Publikováno v:
Internal medicine journal. 47(8)
Multiple myeloma (MM) is a haematological malignancy characterised by the clonal proliferation of plasma cells in the bone marrow. More than 80% of patients with MM display evidence of myeloma bone disease (MBD), characterised by the formation of ost
Publikováno v:
Waldenström’s Macroglobulinemia ISBN: 9783319225838
Understanding the interactions of the immune system and B-cell tumours has great therapeutic potential. Both in myeloma and Waldenstrom’s macroglobulinaemia (WM), there are measurable changes in the immune system with abnormalities of T-cells, NK c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bc45bce4ed3f9b892d68cd6ad39da24
https://doi.org/10.1007/978-3-319-22584-5_8
https://doi.org/10.1007/978-3-319-22584-5_8
Autor:
P. Joy Ho, Derek N.J. Hart, Belinda Pope, John Gibson, Allan Murray, Ross Brown, Daniel M. Sze, Doug Joshua
Publikováno v:
British Journal of Haematology. 125:743-748
The poor response to immunotherapy in patients with multiple myeloma (MM) indicates that a better understanding of any defects in the immune response in these patients is required before effective therapeutic strategies can be developed. Recently we
Publikováno v:
Blood. 96:1274-1279
Deficiencies in B7:CD28 costimulation are considered to be one of the major causes of the failure to generate a tumor-specific immune response. Up-regulating the expression of the B7 molecules on malignant B cells has been shown to stimulate cytotoxi
Autor:
Michael J. Brisco, Pamela J. Sykes, Alec Morley, Ross D. Brown, Xiao-Feng Luo, John Gibson, Doug Joshua
Publikováno v:
American Journal of Hematology. 58:273-277
Individual myeloma cells in the peripheral blood of 7 patients with multiple myeloma were detected by mRNA in situ hybridization (ISH) using biotinylated antisense oligonucleotide probes to non-germline sequences of the CDR3 region of the immunoglobu
Publikováno v:
Leukemia & Lymphoma. 25:545-554
The dysregulation of specific oncogenes due to either mutation or activation has previously been reported in a small number of patients with myeloma but the extent of oncogene dysregulation during the course of the disease is not known. The oncoprote
Publikováno v:
British Journal of Haematology. 94:76-81
For patients with multiple myeloma the most important laboratory correlate of prognosis and disease activity is the bromodeoxyuridine (BrdUrd) plasma cell labelling index (LI). However, the traditional immunofluorescent microscope LI technique, like